155 related articles for article (PubMed ID: 20962274)
21. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
[TBL] [Abstract][Full Text] [Related]
22. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20.
Kishi H; Nakagawa K; Matsumoto M; Suga M; Ando M; Taya Y; Yamaizumi M
J Biol Chem; 2001 Oct; 276(42):39115-22. PubMed ID: 11495913
[TBL] [Abstract][Full Text] [Related]
23. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage.
Burma S; Kurimasa A; Xie G; Taya Y; Araki R; Abe M; Crissman HA; Ouyang H; Li GC; Chen DJ
J Biol Chem; 1999 Jun; 274(24):17139-43. PubMed ID: 10358069
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53.
Ullrich SJ; Sakaguchi K; Lees-Miller SP; Fiscella M; Mercer WE; Anderson CW; Appella E
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5954-8. PubMed ID: 8327466
[TBL] [Abstract][Full Text] [Related]
25. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53.
Cuddihy AR; Li S; Tam NW; Wong AH; Taya Y; Abraham N; Bell JC; Koromilas AE
Mol Cell Biol; 1999 Apr; 19(4):2475-84. PubMed ID: 10082513
[TBL] [Abstract][Full Text] [Related]
26. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
27. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
28. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
29. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
[TBL] [Abstract][Full Text] [Related]
30. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest.
Beckerman R; Yoh K; Mattia-Sansobrino M; Zupnick A; Laptenko O; Karni-Schmidt O; Ahn J; Byeon IJ; Keezer S; Prives C
Cell Cycle; 2016 Jun; 15(11):1425-38. PubMed ID: 27210019
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53.
Sakaguchi K; Sakamoto H; Lewis MS; Anderson CW; Erickson JW; Appella E; Xie D
Biochemistry; 1997 Aug; 36(33):10117-24. PubMed ID: 9254608
[TBL] [Abstract][Full Text] [Related]
32. Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389.
Bruins W; Zwart E; Attardi LD; Iwakuma T; Hoogervorst EM; Beems RB; Miranda B; van Oostrom CT; van den Berg J; van den Aardweg GJ; Lozano G; van Steeg H; Jacks T; de Vries A
Mol Cell Biol; 2004 Oct; 24(20):8884-94. PubMed ID: 15456863
[TBL] [Abstract][Full Text] [Related]
33. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
Kenzelmann Broz D; Attardi LD
Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells.
Akagi M; Yasui W; Akama Y; Yokozaki H; Tahara H; Haruma K; Kajiyama G; Tahara E
Jpn J Cancer Res; 1996 Apr; 87(4):377-84. PubMed ID: 8641969
[TBL] [Abstract][Full Text] [Related]
35. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax.
van Lookeren Campagne M; Gill R
J Comp Neurol; 1998 Jul; 397(2):181-98. PubMed ID: 9658283
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of the antiproliferative function of p53 by phosphorylation at serine 20: an inference from site-directed mutagenesis studies.
Jabbur JR; Huang P; Zhang W
Int J Mol Med; 2001 Feb; 7(2):163-8. PubMed ID: 11172619
[TBL] [Abstract][Full Text] [Related]
37. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
Erker L; Schubert R; Yakushiji H; Barlow C; Larson D; Mitchell JB; Wynshaw-Boris A
Hum Mol Genet; 2005 Jun; 14(12):1699-708. PubMed ID: 15888486
[TBL] [Abstract][Full Text] [Related]
38. p53 and tumor suppression.
Van Dyke T
N Engl J Med; 2007 Jan; 356(1):79-81. PubMed ID: 17202460
[No Abstract] [Full Text] [Related]
39. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.
Ho DH; Kim H; Kim J; Sim H; Ahn H; Kim J; Seo H; Chung KC; Park BJ; Son I; Seol W
Mol Brain; 2015 Sep; 8():54. PubMed ID: 26384650
[TBL] [Abstract][Full Text] [Related]
40. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo.
Jabbur JR; Huang P; Zhang W
Oncogene; 2000 Dec; 19(54):6203-8. PubMed ID: 11175334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
